联合 发表于 2025-3-25 06:15:33

http://reply.papertrans.cn/1/27/2645/2645-21.png

headlong 发表于 2025-3-25 09:57:04

http://reply.papertrans.cn/1/27/2645/2645-22.png

Callus 发表于 2025-3-25 13:15:20

Submitted on: 30 January 2006.
Revised on: 05 April 2006.
Accepted on: 29 May 2006.

___________________Ars Pharmaceutica---UNIV GRANADA, EDITORIAL

MODE 发表于 2025-3-25 17:01:47

Submitted on: 20 March 2022.
Revised on: 04 May 2022.
Accepted on: 19 May 2022.

___________________Ars Pharmaceutica---UNIV GRANADA, EDITORIAL

Preserve 发表于 2025-3-25 22:54:44

http://reply.papertrans.cn/1/27/2645/2645-25.png

执拗 发表于 2025-3-26 03:00:11

Submitted on: 28 August 2016.
Revised on: 17 October 2016.
Accepted on: 28 November 2016.

___________________Ars Pharmaceutica---UNIV GRANADA, EDITORIAL

Cupidity 发表于 2025-3-26 05:58:21

Submitted on: 08 February 2010.
Revised on: 30 March 2010.
Accepted on: 21 May 2010.

___________________Ars Pharmaceutica---UNIV GRANADA, EDITORIAL

使困惑 发表于 2025-3-26 12:31:41

Submitted on: 26 February 2003.
Revised on: 10 June 2003.
Accepted on: 16 July 2003.

___________________Ars Pharmaceutica---UNIV GRANADA, EDITORIAL

obtuse 发表于 2025-3-26 16:19:33

Submitted on: 19 January 2018.
Revised on: 10 February 2018.
Accepted on: 01 March 2018.

___________________Ars Pharmaceutica---UNIV GRANADA, EDITORIAL

冒失 发表于 2025-3-26 20:11:32

http://reply.papertrans.cn/1/27/2645/2645-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊Ars Pharmaceutica 2024/2025影响因子:0.439 (ARS PHARM) (0004-2927). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging Sources